ALS Awareness Facts: Day 24

Lou Gehrig’s disease eventually affects total body movement, as well as speech, swallowing and breathing. ALS ultimately results in a total body paralysis, inability to speak, inability to eat or drink by mouth, and inability to breathe unassisted. Finally there is simply an inability to breathe.

ALS Awareness Facts: Day 20

It’s impossible to detail all the benefits of private insurance providers, but Social Security assistance is something every ALS family should investigate.

ALS Awareness Facts: Day 19

Although the life expectancy of an ALS patient averages about 2-5 years from the time of diagnosis, this disease is variable and many people live with quality for 5 years and more.

Phase 3 Study of Dexpramipexole in ALS (EMPOWER)

We noticed a lot of visitors searching the RASCALS site recently for information regarding Biogen Idec’s Dexpramipexole Phase 3 trials, (a.k.a. NCT01281189).